Imunon, Inc. (IMNN)
NASDAQ: IMNN · Real-Time Price · USD
1.600
-0.010 (-0.62%)
Aug 10, 2026, 10:59 AM EDT - Market open

Imunon Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
----0.50.5
Revenue Growth
----0%0%
Gross Profit
----0.50.5
Operating Income
-14.81-14.65-19.13-21.03-24.92-21.01
Net Income
-14.64-14.5-18.62-19.51-35.9-20.77
Earnings Per Share
-5.17-6.83-16.94-28.17-65.61-49.96
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
4.798.785.8715.732.7549.39
Total Debt
0.911.011.141.626.276.63
Net Cash (Debt)
3.887.774.7314.0726.4842.76
Net Cash Growth
108.31%64.20%-66.36%-46.86%-38.06%289.77%
Net Cash Per Share
1.263.664.3120.2948.36102.76

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-15.03-13.9-18.85-19.02-23.1-16.22
Capital Expenditures
-0.02-0.28-0.03-0.45-0.27-0.31
Free Cash Flow
-15.06-14.18-18.88-19.47-23.36-16.54
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
----100.00%100.00%
Operating Margin
-----4984.31%-4201.44%
Pretax Margin
-----7493.05%-4430.54%
Profit Margin
-----7179.65%-4153.85%
FCF Margin
-----4672.94%-3307.04%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
----23.09107.51